血液流变学在突聋治疗中的研究进展
Advances in Hemorheology in the Treatment of Sudden Sensorineural Hearing Loss
DOI: 10.12677/acm.2024.14123230, PDF,    科研立项经费支持
作者: 崔琬苓, 廖林志, 张 淇, 王 玲, 熊彦青:成都中医药大学临床医学院,四川 成都;蒋路云, 谢 艳*:成都中医药大学附属医院耳鼻咽喉科,四川 成都
关键词: 突聋内耳微循环血液流变学Sudden Sensorineural Hearing Loss Inner Ear Microcirculation Hemorheology
摘要: 突发性感音神经性聋(突聋)是当前耳科领域一种常见且病因尚不明确的疾病。该病近年来有更加年轻化的趋势,尽管部分患者具有一定的自愈能力,但多数患者的预后并不理想,常导致永久性听力损失,进而严重影响其生活质量。该疾病的发病机制错综复杂,内耳微循环障碍是其中一个备受关注的病因。血管的痉挛、狭窄,血液黏度的升高和高凝状态,血栓的形成,栓子的堵塞等因素都会影响内耳微循环,进而导致突聋的发生。针对于此可以采用相关的血液流变学治疗,包括了稀释血液、改善血液流动度以及降低血液黏稠度。具体可以使用巴曲酶、银杏叶提取物等药物达到治疗目的,本文就此血液流变学在突聋中的治疗作出综述。
Abstract: Sudden sensorineural hearing loss (SSHL) is a prevalent yet etiologically unclear disease in the field of otology. In recent years, there has been a trend of younger onset for this condition. Although some patients exhibit a certain degree of spontaneous recovery, the prognosis for the majority is unfavorable, often leading to permanent hearing impairment and subsequently severely impacting their quality of life. The pathogenesis of SSHL is intricate, with microcirculation disorders of the inner ear being a notable etiological factor. Factors such as vascular spasm, stenosis, increased blood viscosity and hypercoagulability, thrombus formation, and embolism obstruction can all affect the microcirculation of the inner ear, ultimately resulting in the occurrence of SSHL. In response to this, relevant hemorheological treatments can be adopted, including blood dilution, improvement of blood fluidity, and reduction of blood viscosity. Specifically, drugs such as batroxobin and ginkgo biloba extract can be used to achieve therapeutic goals. This article provides a comprehensive review of the application of hemorheology in the treatment of SSHL.
文章引用:崔琬苓, 蒋路云, 廖林志, 张淇, 王玲, 熊彦青, 谢艳. 血液流变学在突聋治疗中的研究进展[J]. 临床医学进展, 2024, 14(12): 1385-1390. https://doi.org/10.12677/acm.2024.14123230

参考文献

[1] World Health Organization (2020) Deafness and Hearing Loss.
https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss
[2] Peng, X., Zhu, X.H., Huang, B.Q., et al. (20230 Long-Term Evaluation and Physical and Mental Effects of Residual Tinnitus Following Treatment of Sudden Hearing Loss. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 58, 42-46.[CrossRef] [PubMed]
[3] 刘丹, 单春光, 张玉波. 突发性聋病因学研究进展[J]. 听力学及言语疾病杂志, 2019, 27(6): 677-680.
[4] 陈鹏, 任金龙, 王银霞. 微循环障碍危险因素与突发性耳聋的研究进展[J]. 河北医药, 2022, 44(4): 608-613.
[5] 佟美双, 詹俊杰. 内耳微循环障碍在突发性耳聋中的作用[J]. 微量元素与健康研究, 2021(4): 65-67.
[6] Feng, T., Zhang, Q., Wei, J., Wang, X. and Geng, Y. (2022) Effects of Alprostadil Combined with Hyperbaric Oxygen on Hearing Recovery and Hemorheology in Patients with Sudden Sensorineural Hearing Loss and Analysis of Related Influencing Factors. Experimental and Therapeutic Medicine, 23, Article No. 242. [Google Scholar] [CrossRef] [PubMed]
[7] Chen, L., Wang, Y., Gao, X., Xiong, W., Duan, F., Zhang, N., et al. (2022) Thromboelastography Predicting the Prognosis of Sudden Sensorineural Hearing Loss. Clinical Otolaryngology, 47, 724-731. [Google Scholar] [CrossRef] [PubMed]
[8] Yamada, S., Kita, J., Shinmura, D., Nakamura, Y., Sahara, S., Misawa, K., et al. (2022) Update on Findings about Sudden Sensorineural Hearing Loss and Insight into Its Pathogenesis. Journal of Clinical Medicine, 11, Article 6387. [Google Scholar] [CrossRef] [PubMed]
[9] 中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会. 突发性聋诊断和治疗指南(2015) [J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(6): 443-447.
[10] Chandrasekhar, S.S., Tsai Do, B.S., Schwartz, S.R., Bontempo, L.J., Faucett, E.A., Finestone, S.A., et al. (2019) Clinical Practice Guideline: Sudden Hearing Loss (Update). OtolaryngologyHead and Neck Surgery, 161, S1-S45. [Google Scholar] [CrossRef] [PubMed]
[11] 北京脑血管病防治协会, 银杏叶提取物注射液临床应用专家共识写作组. 银杏叶提取物注射液临床应用中国专家共识(2019) [J]. 中华老年医学杂志, 2019, 38(11): 1198-1204.
[12] Xu, X. and Teng, X. (2015) Effect of Fibrinogen on Blood Coagulation Detected by Optical Coherence Tomography. Physics in Medicine and Biology, 60, 4185-4195. [Google Scholar] [CrossRef] [PubMed]
[13] 马昕, 尤慧华. 血浆纤维蛋白原水平与突发性聋发病及预后关系探讨[C]//浙江省医学会耳鼻咽喉头颈外科学分会. 2020年浙江省医学会耳鼻咽喉头颈外科学学术大会论文汇编. 2020: 59-60.
[14] 鲍凤香, 张燕平, 刘伟伟. 突发性聋与血脂代谢异常和血浆纤维蛋白原增高的相关性分析[J]. 听力学及言语疾病杂志, 2015(2): 156-159.
[15] 王倩滢, 钟时勋. 巴曲酶在不同类型突发性耳聋治疗中的应用[J]. 中华耳科学杂志, 2018, 16(2): 239-243.
[16] Kim, J., Jeong, J., Ha, R. and Sunwoo, W. (2019) Heparin Therapy as Adjuvant Treatment for Profound Idiopathic Sudden Sensorineural Hearing Loss. The Laryngoscope, 130, 1310-1315. [Google Scholar] [CrossRef] [PubMed]
[17] Sunwoo, W. (2022) Basilar Artery Tortuosity as a Predictive Factor for the Efficacy of Heparin Adjuvant Therapy in Unilateral Idiopathic Sudden Sensorineural Hearing Loss. Brazilian Journal of Otorhinolaryngology, 88, 381-389. [Google Scholar] [CrossRef] [PubMed]
[18] 林伟. 巴曲酶联合甲泼尼龙治疗全频下降型突聋的应用及临床疗效评价[J]. 中外医疗, 2023, 42(26): 94-97.
[19] 孙小春, 陈长祥. 巴曲霉联合前列地尔治疗突发性耳聋患者的疗效观察[J]. 血栓与止血学, 2021(4): 646-647+649.
[20] 王天宇, 刘映岐, 梁才全, 戴鹏飞, 邹庆云, 周梦夏, 刘环海. 巴曲酶联合常规治疗对不同类型突发性聋患者的疗效观察[J]. 中国耳鼻咽喉颅底外科杂志, 2021(2): 196-200.
[21] 李嘉文. 巴曲酶治疗突发性耳聋的临床疗效分析[D]: [硕士学位论文]. 大理: 大理大学, 2022.
[22] 龚莉, 苏述平, 田晓江, 唐学文, 季欢欢, 蒙龙, 贾运涛. 巴曲酶治疗突发性聋的疗效及安全性的Meta分析[J]. 中国药物警戒, 2021(10): 969-974.
[23] 董超, 马萱, 史延茂. 血栓病治疗药物-纤溶酶的生物来源[J]. 生物信息学, 2019(2): 76-85.
[24] 徐能, 肖芝. 巴曲酶注射液联合纤溶酶注射液治疗突发性耳聋患者的效果分析[J]. 医学理论与实践, 2024, 37(12): 2064-2066+2084.
[25] 董和霞, 王晓辉. 纤溶酶治疗全聋型或接近全聋型突发性聋的疗效观察[J]. 中华耳科学杂志, 2011(3): 300-302.
[26] 张艳丽, 段晓辉. 纤溶酶治疗突发性聋的临床疗效与分析[J]. 南昌大学学报(医学版), 2013(8): 22-24+31.
[27] Mitchell, P.J., Yan, B., Brozman, M., Ribo, M., Marder, V., Courtney, K.L., et al. (2017) Plasmin (Human) Administration in Acute Middle Cerebral Artery Ischemic Stroke: Phase 1/2a, Open-Label, Dose-Escalation, Safety Study. Journal of Stroke and Cerebrovascular Diseases, 26, 308-320. [Google Scholar] [CrossRef] [PubMed]
[28] 王霞, 陈彩梅. 耳后注射甲泼尼龙琥珀酸钠联合纤溶酶治疗重度及极重度突发性耳聋患者的疗效观察[J]. 血栓与止血学, 2022, 28(2): 225-227.
[29] Frederiksen, T.W., Ramlau-Hansen, C.H., Stokholm, Z.A., Brødsgaard Grynderup, M., Hansen, Å.M., Lund, S.P., et al. (2014) Atherogenic Risk Factors and Hearing Thresholds. Audiology and Neurotology, 19, 310-318. [Google Scholar] [CrossRef] [PubMed]
[30] Marcucci, R., Alessandrello Liotta, A., Cellai, A.P., Rogolino, A., Berloco, P., Leprini, E., et al. (2005) Cardiovascular and Thrombophilic Risk Factors for Idiopathic Sudden Sensorineural Hearing Loss. Journal of Thrombosis and Haemostasis, 3, 929-934. [Google Scholar] [CrossRef] [PubMed]
[31] Merchant, S.N., Adams, J.C. and Nadol, J.B. (2005) Pathology and Pathophysiology of Idiopathic Sudden Sensorineural Hearing Loss. Otology & Neurotology, 26, 151-160. [Google Scholar] [CrossRef] [PubMed]
[32] 段丹丹, 张雅君. 巴曲酶注射液与注射用纤溶酶治疗急性缺血性脑卒中的有效性及经济性研究[J]. 中国药物应用与监测, 2022(1): 1-3+15.
[33] 江刚, 郭梦和, 文忠, 等. 纤溶酶治疗突发性聋的疗效观察[J]. 临床耳鼻咽喉科杂志, 2005(22): 43-44.